Szwergold B S, Ugurbil K, Brown T R
Department of NMR and Medical Spectroscopy, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111.
Arch Biochem Biophys. 1995 Feb 20;317(1):244-52. doi: 10.1006/abbi.1995.1159.
A class II Zn(2+)-dependent fructose-1,6-bisphosphate (FBP)- aldolase was purified from an overproducer strain of Escherichia coli and characterized by standard biochemical techniques and 13C NMR spectroscopy. The principal finding of these studies was identification, by 13C NMR spectroscopy, of an enzyme-bound reaction intermediate, the enediol(ate) form of dihydroxyacetone phosphate (DHAP). Formation of this intermediate requires the presence of Zn2+ and is pH dependent, with increasing amounts of this tautomer appearing at alkaline pH's. This pH dependence closely parallels the pH activity profile of the enzyme, suggesting an involvement of the enediol-DHAP form in the reaction pathway. In addition to these results the following observations were made on this enzyme: (a) E. coli FBP aldolase binds and utilizes only the carbonyl forms of FBP and DHAP; (b) the function of Zn2+ in this metalloaldolase appears to be polarization of the C = O bond of DHAP; (c) activity of this enzyme is unaffected by glycolytic intermediates or nucleotide phosphates such as ATP. Although these studies provide some information about the catalytic mechanism of E. coli FBP aldolase, they do not provide an explanation for the apparent regulation of this enzyme reported in previous in vivo NMR studies. While the possibility that the enzyme is allosterically regulated cannot be excluded at this time, an interesting possibility suggested by this and other studies is that in E. coli glycolytic substrates may be channeled through a multienzyme complex.
从大肠杆菌高产菌株中纯化出一种II类锌离子依赖性果糖-1,6-二磷酸(FBP)醛缩酶,并用标准生化技术和13C核磁共振光谱对其进行了表征。这些研究的主要发现是,通过13C核磁共振光谱鉴定出一种酶结合反应中间体,即磷酸二羟丙酮(DHAP)的烯二醇(盐)形式。这种中间体的形成需要锌离子的存在,并且依赖于pH值,在碱性pH值下这种互变异构体的量会增加。这种pH依赖性与酶的pH活性曲线密切平行,表明烯二醇-DHAP形式参与了反应途径。除了这些结果外,还对该酶进行了以下观察:(a)大肠杆菌FBP醛缩酶仅结合并利用FBP和DHAP的羰基形式;(b)锌离子在这种金属醛缩酶中的作用似乎是使DHAP的C = O键极化;(c)该酶的活性不受糖酵解中间体或核苷酸磷酸(如ATP)的影响。尽管这些研究提供了一些关于大肠杆菌FBP醛缩酶催化机制的信息,但它们没有对先前体内核磁共振研究中报道的该酶的明显调节作用做出解释。虽然目前不能排除该酶受到变构调节的可能性,但这项研究和其他研究提出的一个有趣可能性是,在大肠杆菌中,糖酵解底物可能通过多酶复合物进行通道运输。